Essential Fatty Acids and Lipids — MCQs
A patient with high triglycerides (TG) esterified with long-chain fatty acids (LCFA) presents with fatigue, and a biopsy of the muscle shows fat vacuoles. What is the most likely diagnosis?
Which two enzymes are required for the beta oxidation of polyunsaturated fatty acids (PUFA)?
All of the following are products of the cyclooxygenase pathway from arachidonic acid, except for:
The fatty acid present in breast milk which is important for growth and CNS development is:
Essential fatty acid:
Dietary fibres have :
Which food item among the following has the highest protein content?
A young girl presents to the outpatient department with rough-surfaced lesions over her elbows and knees. She also complains of diminished vision at night. What is the most likely diagnosis?
Which type of fatty acids should be included in the diet to manage chyluria?
Which of the following is a metabolic disorder inherited in an X-linked manner?
Essential Fatty Acids and Lipids Indian Medical PG Practice Questions and MCQs
Question 1: A patient with high triglycerides (TG) esterified with long-chain fatty acids (LCFA) presents with fatigue, and a biopsy of the muscle shows fat vacuoles. What is the most likely diagnosis?
- A. Carnitine deficiency (Correct Answer)
- B. Fatty acid synthase defect
- C. Lipoprotein lipase (LPL) defect
- D. LDL defect
- E. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency
Explanation: ***Carnitine deficiency*** - **Carnitine** is essential for transporting **long-chain fatty acids (LCFAs)** into the mitochondria for beta-oxidation. - A deficiency leads to the accumulation of **LCFAs** as **triglycerides** in the cytoplasm, resulting in **fat vacuoles** in muscle and systemic fatigue due to impaired energy production. *Fatty acid synthase defect* - **Fatty acid synthase** is involved in the *de novo* synthesis of fatty acids, not their catabolism or transport. - A defect would impair fatty acid production, not lead to the accumulation of **triglycerides** from exogenous sources. *Lipoprotein lipase (LPL) defect* - **LPL** is crucial for cleaving **triglycerides** in circulating chylomicrons and VLDL, allowing fatty acids to be taken up by tissues. - A defect causes severe hypertriglyceridemia, but the primary issue in the muscle with fat vacuoles points towards a problem with intracellular fatty acid utilization rather than plasma triglyceride clearance. *LDL defect* - **LDL** is primarily responsible for transporting cholesterol to peripheral tissues. - Defects in **LDL** metabolism typically lead to hypercholesterolemia, not the accumulation of **triglycerides** or muscle fat vacuoles as described. *Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency* - **MCAD** deficiency is a fatty acid oxidation disorder affecting **medium-chain fatty acids** (C6-C12), not the **long-chain fatty acids** specifically mentioned in the stem. - It typically presents with hypoketotic hypoglycemia during fasting, often in infancy or childhood, rather than the characteristic muscle fat vacuole accumulation pattern seen with **carnitine deficiency**.
Question 2: Which two enzymes are required for the beta oxidation of polyunsaturated fatty acids (PUFA)?
- A. Dienoyl CoA isomerase and Enoyl CoA isomerase
- B. Dienoyl CoA isomerase and 2,4 Dienoyl CoA reductase
- C. Enoyl CoA isomerase and Enoyl CoA reductase
- D. Enoyl CoA isomerase and 2,4 Dienoyl CoA reductase (Correct Answer)
Explanation: **Enoyl CoA isomerase and 2,4 Dienoyl CoA reductase** - **Enoyl CoA isomerase** is necessary to convert *cis* double bonds to *trans* double bonds at the 3,4 position, which allows the beta-oxidation enzymes to continue processing the fatty acid. - **2,4 Dienoyl CoA reductase** is required to reduce *cis-2, cis-4* or *trans-2, cis-4* dienoyl intermediates into a single *trans-3* enoyl CoA, which can then be isomerized by enoyl CoA isomerase. *Dienoyl CoA isomerase and Enoyl CoA isomerase* - This option is incorrect because **Dienoyl CoA isomerase** is not a commonly recognized single enzyme directly involved in PUFA beta-oxidation in the way described. The key is to reduce a diene, which reductase does. - While **Enoyl CoA isomerase** is crucial, pairing it with another isomerase in this context does not fully address the reduction step needed for certain PUFAs. *Dienoyl CoA isomerase and 2,4 Dienoyl CoA reductase* - This option incorrectly names **Dienoyl CoA isomerase** as one of the two main required enzymes. A 2,4 Dienoyl CoA reductase does exist. - While **2,4 Dienoyl CoA reductase** is essential, the other enzyme should be Enoyl CoA isomerase to handle the initial *cis* to *trans* isomerizations. *Enoyl CoA isomerase and Enoyl CoA reductase* - This option is incorrect because **Enoyl CoA reductase** without the "2,4" prefix generally refers to the enzyme involved in fatty acid synthesis, not beta-oxidation of PUFAs. - **Enoyl CoA isomerase** is correctly identified, but the other enzyme specifically for PUFA oxidation is the **2,4 Dienoyl CoA reductase**.
Question 3: All of the following are products of the cyclooxygenase pathway from arachidonic acid, except for:
- A. PGE2
- B. PGD2
- C. PGF2α
- D. LTD4 (Correct Answer)
Explanation: ***LTD4*** - Leukotriene D4 (**LTD4**) is a product of the **lipoxygenase pathway**, not the cyclooxygenase pathway, from arachidonic acid. - It plays a significant role in **bronchoconstriction** and inflammation, especially in asthma. *PGE2* - **Prostaglandin E2 (PGE2)** is a major product of the **cyclooxygenase (COX) pathway**. - It is involved in mediating **fever**, pain, and inflammation. *PGD2* - **Prostaglandin D2 (PGD2)** is also produced via the **cyclooxygenase (COX) pathway**. - It is primarily associated with allergic reactions, **bronchoconstriction**, and sleep regulation. *PGF2α* - **Prostaglandin F2 alpha (PGF2α)** is a product derived from arachidonic acid through the **cyclooxygenase (COX) pathway**. - It plays a role in **uterine contractions**, fertility, and vascular tone.
Question 4: The fatty acid present in breast milk which is important for growth and CNS development is:
- A. Docosahexaenoic acid (Correct Answer)
- B. Palmitic acid
- C. Linolenic acid
- D. Linoleic acid
Explanation: ***Docosahexaenoic acid*** - **Docosahexaenoic acid (DHA)** is a crucial **omega-3 fatty acid** abundantly found in breast milk. - It plays a vital role in the **development of the brain** and **retina**, particularly during infancy. *Palmitic acid* - **Palmitic acid** is a **saturated fatty acid** and a major component of fats in both plants and animals, including breast milk. - While it serves as an **energy source**, it is not primarily recognized for its specific role in CNS development like DHA. *Linolenic acid* - **Alpha-linolenic acid (ALA)** is an **omega-3 essential fatty acid** that is a precursor to DHA and EPA, meaning the body can convert it into these longer-chain fatty acids. - While important as a precursor, **ALA itself is not the direct fatty acid** primarily responsible for brain and CNS development in the same way DHA is. *Linoleic acid* - **Linoleic acid** is an **omega-6 essential fatty acid**, meaning the body cannot produce it and it must be obtained from the diet. - It is important for overall growth and development, but it is not specifically highlighted for its direct role in **CNS development** in the same way DHA is for breast milk.
Question 5: Essential fatty acid:
- A. Citric acid
- B. Palmitic acid
- C. Linoleic acid (Correct Answer)
- D. Stearic acid
Explanation: ***Linoleic acid*** - **Linoleic acid** is an **omega-6 fatty acid** that is considered essential because the human body cannot synthesize it and must obtain it through diet. - It is a precursor for other important fatty acids like **arachidonic acid**, which are involved in inflammation and blood clotting. *Citric acid* - **Citric acid** is an organic acid found in citrus fruits and is a key intermediate in the **Krebs cycle** (citric acid cycle), a central metabolic pathway, but it is not a fatty acid. - It is readily synthesized by the body and is therefore not considered an essential nutrient. *Palmitic acid* - **Palmitic acid** is a **saturated fatty acid** with 16 carbon atoms, which is the most common fatty acid in animals and plants. - It can be synthesized by the human body from excess carbohydrates and proteins, hence it is not an essential fatty acid. *Stearic acid* - **Stearic acid** is another common **saturated fatty acid** with 18 carbon atoms, found in various animal and plant fats. - Like palmitic acid, it can be endogenously synthesized by the body and is not considered essential.
Question 6: Dietary fibres have :
- A. catabolic effect
- B. sometimes anabolic and sometimes catabolic effect, depending on the type
- C. anabolic effect
- D. no metabolic effect (Correct Answer)
Explanation: ***no metabolic effect*** - Dietary fibers are **indigestible polysaccharides** that cannot be broken down by human digestive enzymes. - Humans lack enzymes like **cellulase** necessary to hydrolyze the β-glycosidic bonds in dietary fiber. - Dietary fibers pass through the gastrointestinal tract **without being metabolized** by human cells, meaning they do not participate in anabolic or catabolic pathways. - While gut bacteria can ferment some fibers producing short-chain fatty acids (SCFAs), this is **bacterial metabolism**, not human metabolism. - The physiological effects of fiber (improved bowel motility, reduced cholesterol absorption, glycemic control) are **mechanical and physicochemical**, not metabolic. *catabolic effect* - Catabolic processes involve **breakdown of molecules with energy release** (e.g., glycolysis, lipolysis). - Dietary fibers cannot undergo catabolism in humans because we lack the enzymes to break them down. - The fermentation by gut bacteria is not human catabolism. *anabolic effect* - Anabolic processes involve **synthesis of complex molecules** from simpler ones (e.g., protein synthesis, glycogenesis). - Dietary fibers are not absorbed or incorporated into human tissues, so they cannot participate in anabolic reactions. *sometimes anabolic and sometimes catabolic effect, depending on the type* - Regardless of fiber type (soluble or insoluble), **all dietary fibers remain non-metabolizable** by human enzymes. - Neither type undergoes anabolic or catabolic metabolism in human cells.
Question 7: Which food item among the following has the highest protein content?
- A. Egg
- B. Soyabean (Correct Answer)
- C. Rice
- D. Wheat
Explanation: ***Soyabean*** - **Soybeans** are an exceptional source of **complete protein**, containing all nine essential amino acids - They provide approximately **36 grams of protein per 100 grams**, making them one of the most protein-rich plant foods - Due to their high protein content and versatility, soybeans and soy-based products are staple foods in many diets, especially for vegetarians and vegans *Egg* - Eggs are a complete protein source with excellent bioavailability and quality - A whole egg typically contains about **6 grams of protein** (approximately 13 grams per 100 grams) - While eggs are an excellent protein source, **soybeans contain significantly higher protein per 100 grams** *Rice* - **Rice**, particularly white rice, is primarily a source of **carbohydrates** with relatively low protein content - Contains approximately **2-3 grams of protein per 100 grams** - Not considered a significant source of protein compared to legumes or animal products *Wheat* - **Wheat** is a grain rich in carbohydrates with moderate protein content - Contains approximately **10-15 grams of protein per 100 grams**, particularly in whole wheat - While it's a good source of plant-based protein, it contains significantly less protein than **soybeans**
Question 8: A young girl presents to the outpatient department with rough-surfaced lesions over her elbows and knees. She also complains of diminished vision at night. What is the most likely diagnosis?
- A. Folliculitis
- B. Pyoderma
- C. Keratosis pilaris
- D. Phrynoderma (Correct Answer)
Explanation: ***Phrynoderma*** - Phrynoderma, also known as **follicular hyperkeratosis**, presents with **rough, horny papules** over extensor surfaces like elbows and knees, often described as "toad skin." - It is a skin manifestation of **vitamin A deficiency**, which also causes **night blindness** (nyctalopia) due to impaired production of rhodopsin. *Folliculitis* - This is an **inflammation of hair follicles**, appearing as small, red bumps or pustules centered around hair follicles. - It is typically caused by bacterial or fungal infections and does not cause **night blindness**. *Pyoderma* - **Pyoderma** refers to a **pus-producing skin infection** caused by bacteria, such as impetigo or cellulitis. - These are characterized by crusts, blisters, or inflamed lesions and are not associated with **rough skin** or **night blindness**. *Keratosis pilaris* - This common genetic condition causes small, rough bumps, typically on the upper arms, thighs, and buttocks, due to **keratin plugging hair follicles**. - While it causes rough skin similar to phrynoderma, it is generally **benign** and does not cause systemic symptoms like **night blindness**.
Question 9: Which type of fatty acids should be included in the diet to manage chyluria?
- A. Short-chain fatty acids
- B. Medium-chain fatty acids (Correct Answer)
- C. Long-chain fatty acids
- D. Omega-3 fatty acids
Explanation: ***Medium-chain fatty acids*** - **Medium-chain fatty acids (MCFAs)** are absorbed directly into the **portal circulation** without being re-esterified to triglycerides or incorporated into chylomicrons [1]. This helps bypass the compromised lymphatic system. - In **chyluria**, the lymphatic system's integrity is disrupted, leading to leakage of **chyle** (lymphatic fluid rich in chylomicrons) into the urinary tract. MCFAs provide a source of fat that does not rely on the lymphatic pathway for transport [1]. *Short-chain fatty acids* - **Short-chain fatty acids (SCFAs)** are primarily produced by bacterial fermentation in the colon and are absorbed directly into the portal circulation. - While they do not rely on the lymphatic system, their dietary contribution as a significant energy source is limited, and they are not the primary fat source for patients with chyluria. *Long-chain fatty acids* - **Long-chain fatty acids (LCFAs)** are absorbed with the help of bile salts, re-esterified into triglycerides, and packaged into **chylomicrons** within the intestinal cells [2]. - These chylomicrons then enter the **lymphatic system** and eventually the bloodstream, which is precisely the pathway that is compromised in chyluria, making them unsuitable [2]. *Omega-3 fatty acids* - **Omega-3 fatty acids** are a type of **long-chain polyunsaturated fatty acid** that also follow the chylomicron-lymphatic pathway for absorption [3]. - While beneficial for other health aspects, they are not suitable for managing chyluria due to their reliance on the **lymphatic system** for transport, which is dysfunctional in this condition.
Question 10: Which of the following is a metabolic disorder inherited in an X-linked manner?
- A. Duchenne muscular dystrophy
- B. Adrenoleukodystrophy (Correct Answer)
- C. Phenylketonuria
- D. Marfan syndrome
Explanation: ***Adrenoleukodystrophy*** - **Adrenoleukodystrophy (ALD)** is an **X-linked recessive disorder** that affects the metabolism of very long-chain fatty acids (VLCFAs). - It leads to the demyelination of nerve cells in the brain and spinal cord, as well as adrenal gland insufficiency. *Phenylketonuria* - **Phenylketonuria (PKU)** is an **autosomal recessive metabolic disorder** caused by a defect in the enzyme phenylalanine hydroxylase. - It results in the accumulation of phenylalanine, leading to intellectual disability if not treated with a specialized diet. *Duchenne muscular dystrophy* - While **Duchenne muscular dystrophy (DMD)** is indeed an **X-linked recessive disorder**, it is primarily a muscle disorder, not a metabolic disorder in the classic sense. - It involves a mutation in the **dystrophin gene**, leading to progressive muscle degeneration and weakness. *Marfan syndrome* - **Marfan syndrome** is an **autosomal dominant disorder** affecting connective tissue. - It is caused by a mutation in the **FBN1 gene**, which codes for fibrillin-1, and primarily affects the skeletal, ocular, and cardiovascular systems.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free